Furthermore, the expression of MIAT was potently different in EVs from serum samples of patients with paroxysmal AF, persistent AF, and permanent AF, with the highest expression observed in the EVs from serum samples of permanent AF patients (Table S3). This evidence concerns the gene MIAT and Paroxysmal atrial fibrillation.